These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22891207)

  • 1. Liver injury in the elderly due to fluoroquinolones: should these drugs be avoided?
    Hayashi PH; Chalasani NP
    CMAJ; 2012 Oct; 184(14):1555-6. PubMed ID: 22891207
    [No Abstract]   [Full Text] [Related]  

  • 2. [Moxifloxacin and hepatic toxicity].
    Franco Hidalgo S; Prieto de Paula JM; García Lorenzo R; Salado Valdivieso I
    Gastroenterol Hepatol; 2009 Dec; 32(10):719-20. PubMed ID: 19664854
    [No Abstract]   [Full Text] [Related]  

  • 3. Fluoroquinolone therapy and idiosyncratic acute liver injury: a population-based study.
    Paterson JM; Mamdani MM; Manno M; Juurlink DN;
    CMAJ; 2012 Oct; 184(14):1565-70. PubMed ID: 22891208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatotoxicity in the treatment of tuberculosis using moxifloxacin-containing regimens.
    Roberts CH; Smith C; Breen R; Gadhok R; Murphy M; Aryee A; Cropley I; Bhagani S; Hopkins S; Lipman M
    Int J Tuberc Lung Dis; 2011 Sep; 15(9):1275-6. PubMed ID: 21943863
    [No Abstract]   [Full Text] [Related]  

  • 5. Moxifloxacin-induced rhabdomyolysis.
    Sanjith S; Raodeo A; Clerk A; Pandit R; Karnad DR
    Intensive Care Med; 2012 Apr; 38(4):725. PubMed ID: 22323079
    [No Abstract]   [Full Text] [Related]  

  • 6. Recurrent episodes of hypoglycemia induced by moxifloxacin.
    Singal DK; Mittal A; Prakash A
    Indian J Pharmacol; 2013; 45(3):301-2. PubMed ID: 23833380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prulifloxacin ECG study.
    Rosignoli MT; Dionisio P
    Clin Drug Investig; 2010; 30(4):275-7. PubMed ID: 20429098
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute iris depigmentation following systemic moxifloxacin.
    Nascimento HM; Sousa JM; Campos MS; Belfort R
    Clinics (Sao Paulo); 2013 Jul; 68(7):899-900. PubMed ID: 23917650
    [No Abstract]   [Full Text] [Related]  

  • 9. Moxifloxacin: new indication. Inadequate restriction of indications in ENT and respiratory infections.
    Prescrire Int; 2009 Oct; 18(103):206. PubMed ID: 19882787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug Points: tachycardia associated with moxifloxacin.
    Siepmann M; Kirch W
    BMJ; 2001 Jan; 322(7277):23. PubMed ID: 11141146
    [No Abstract]   [Full Text] [Related]  

  • 11. Choice of baseline in parallel thorough QT studies.
    Graff C
    Drug Saf; 2013 Jun; 36(6):389-92. PubMed ID: 23620171
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fatal acute hepatitis and cholestasis associated with liver disease].
    Puerto Alonso JL; Díaz Souza P; Chamorro Mohedano J; Rojas Martín E
    Med Clin (Barc); 2010 Mar; 134(8):375-6. PubMed ID: 19447449
    [No Abstract]   [Full Text] [Related]  

  • 13. The safety profile of moxifloxacin and other fluoroquinolones in special patient populations.
    Iannini PB
    Curr Med Res Opin; 2007 Jun; 23(6):1403-13. PubMed ID: 17559736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerance of moxifloxacin-containing regimens in the treatment of tuberculosis.
    Fung SL; Yan SW; Chau CH; Yew WW
    Int J Tuberc Lung Dis; 2012 Feb; 16(2):282-3. PubMed ID: 22236937
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug-induced immune thrombocytopenia due to moxifloxacin.
    Coker TJ
    BMJ Case Rep; 2013 Jan; 2013():. PubMed ID: 23329709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of hepatotoxicity associated with fluoroquinolones: a national case-control safety study.
    Alshammari TM; Larrat EP; Morrill HJ; Caffrey AR; Quilliam BJ; LaPlante KL
    Am J Health Syst Pharm; 2014 Jan; 71(1):37-43. PubMed ID: 24352180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent tendinitis after treatment with two different fluoroquinolones.
    Burkhardt O; Köhnlein T; Pap T; Welte T
    Scand J Infect Dis; 2004; 36(4):315-6. PubMed ID: 15198194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moxifloxacin-induced acute liver injury.
    Soto S; López-Rosés L; Avila S; Lancho A; González A; Santos E; Urraca B
    Am J Gastroenterol; 2002 Jul; 97(7):1853-4. PubMed ID: 12135060
    [No Abstract]   [Full Text] [Related]  

  • 19. Arrhythmias associated with fluoroquinolone therapy.
    Falagas ME; Rafailidis PI; Rosmarakis ES
    Int J Antimicrob Agents; 2007 Apr; 29(4):374-9. PubMed ID: 17241772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moxifloxacin-induced hypoglycemia in a non-diabetic patient.
    Mandavia DR; Virpariya MM; Patel TK; Tripathi CB
    Curr Drug Saf; 2012 Apr; 7(2):183-5. PubMed ID: 22873504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.